- Home
- JAGX vs PPIH Comparison
JAGX vs PPIH Comparison
Compare JAGX & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- PPIH
- Stock Information
- Founded
- JAGX 2013
- PPIH 1993
- Country
- JAGX United States
- PPIH United States
- Employees
- JAGX 49
- PPIH N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- PPIH Pollution Control Equipment
- Sector
- JAGX Health Care
- PPIH Industrials
- Exchange
- JAGX Nasdaq
- PPIH Nasdaq
- Market Cap
- JAGX 3.1M
- PPIH N/A
- IPO Year
- JAGX N/A
- PPIH N/A
- Fundamental
- Price
- JAGX $4.85
- PPIH $11.61
- Analyst Decision
- JAGX
- PPIH
- Analyst Count
- JAGX 0
- PPIH 0
- Target Price
- JAGX N/A
- PPIH N/A
- AVG Volume (30 Days)
- JAGX 37.8K
- PPIH 21.4K
- Earning Date
- JAGX 03-31-2025
- PPIH 04-25-2025
- Dividend Yield
- JAGX N/A
- PPIH N/A
- EPS Growth
- JAGX N/A
- PPIH 213.23
- EPS
- JAGX N/A
- PPIH 1.98
- Revenue
- JAGX $11,689,000.00
- PPIH $153,576,000.00
- Revenue This Year
- JAGX $18.18
- PPIH N/A
- Revenue Next Year
- JAGX $40.06
- PPIH N/A
- P/E Ratio
- JAGX N/A
- PPIH $6.27
- Revenue Growth
- JAGX 19.75
- PPIH 4.52
- 52 Week Low
- JAGX $4.41
- PPIH $6.83
- 52 Week High
- JAGX $540.00
- PPIH $17.58
- Technical
- Relative Strength Index (RSI)
- JAGX 20.48
- PPIH 30.86
- Support Level
- JAGX $4.41
- PPIH $13.68
- Resistance Level
- JAGX $5.45
- PPIH $14.09
- Average True Range (ATR)
- JAGX 0.95
- PPIH 0.55
- MACD
- JAGX 0.00
- PPIH -0.13
- Stochastic Oscillator
- JAGX 3.54
- PPIH 4.00
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.